Around the Web — 1.4.23
Under revisions announced yesterday by FDA, any pharmacy certified under the Mifepristone REMS Program can now dispense the drug. Previously, distribution was limited to certain
Michael Posey
January 4, 2023
Under revisions announced yesterday by FDA, any pharmacy certified under the Mifepristone REMS Program can now dispense the drug. Previously, distribution was limited to certain
FDA last week approved ublituximab-xiiy (Briumvi, TG Therapeutics) for treating adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease,
The FDA is exploring ways it can regulate CBD in foods and supplements, the Wall Street Journal reports. “The FDA has approved a drug named
FDA last week approved lenacapavir (Sunlenca, Gilead), the first of a new capsid inhibitor class, for combination therapy in heavily treatment-experienced adults with multidrug-resistant (MDR)
In a phase 2/3 multicenter trial, a 24-week, all-oral regimen was noninferior to and safer than the currently accepted treatment for rifampin-resistant tuberculosis. Conducted in
FDA yesterday approved a new indication for tocilizumab (Actemra, Genentech) injection for the treatment of hospitalized adult patients with COVID-19 who are receiving systemic corticosteroids
FDA yesterday released the findings and recommendations of an expert panel that evaluated the agency’s Tobacco Program. The panel assessed the Tobacco Program’s regulatory processes
FDA on Friday approved nadofaragene firadenovec-vncg (Adstiladrin, Ferring Pharmaceuticals A/S), a nonreplicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk
FDA this week granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics), a RAS GTPase family inhibitor, for adult patients with KRASG12C-mutated locally advanced or metastatic
Homeopathic products intended for use by those with weakened immune systems, infants and children, older adults, and pregnant women, as well as ophthalmic and injectable